PROGRESS OF DEVELOPMENT

临床试验三期以后的公开信息

药品剂型特性适应症状态(地区)
DifluprednateEye dropCorticosteroidsinflammation associated with ocular surgery, UveitisApproved (Russia)
SJP-0132Eye dropNovel mechanism of actionDry eyeP3(Japan)
SJP-0135Eye dropFixed combinationGlaucomaP3(Japan)
SJP-0008Oral tabletNovel mechanism of actionCentral Retinal Artery Occlusion (CRAO)P3(Japan)
2024年1月現在